AGM Statement

RNS Number : 9721F

Futura Medical PLC

05 May 2011

 



For immediate release

5 May 2011

Futura Medical plc

("Futura" or "the Company")

AGM Statement

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, will hold its Annual General Meeting in London later today.

At the meeting, Dr William Potter, the Company's Chairman, will make the following statement:

"The current financial year has started well for Futura, and we look forward to the commercial launch of PET500 and to the award of the CE mark for CSD500.

"Futura is on the threshold of becoming a company that benefits from significant royalty income. We look to the future with confidence."

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Jessica Fontaine	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

NOAUSRKRAAAVRAR